Owlet Releases 2025 Baby Sleep Report Monitoring 1.2 Million Infants
- Data-Driven Insights: Owlet's inaugural annual Baby Sleep Report, based on monitoring data from over 1.2 million infants in 2025, analyzes nearly 900 million hours of infant sleep, providing parents with insights into the connection between sleep patterns and overall wellness.
- Health Risk Warning: According to the CDC, approximately 40% of infants aged 4-11 months experience short sleep duration, which is linked to physical and mental health issues; Owlet's report offers practical insights for parents to address these concerns.
- Smart Monitoring Product Advantage: Owlet's Dream Sock® is the only FDA-cleared smart baby wearable monitor on the market, helping families interpret sleep patterns and identify meaningful trends, thereby enhancing parents' confidence in their infants' sleep habits.
- Enhanced User Experience: The Owlet360™ membership service provides deeper trends and analytics, supporting parents in understanding changes in nightly sleep patterns, further solidifying Owlet's leadership in the data-driven infant health sector.
Trade with 70% Backtested Accuracy
Analyst Views on OWLT
About OWLT
About the author

- Strategic Partnership: Owlet has formed a strategic partnership with leading private AI platform webAI to accelerate the development of secure, personalized, and data-driven intelligence, thereby enhancing the competitive edge and user experience of Owlet's product ecosystem.
- Long-term AI Strategy: Owlet views AI as a long-term platform investment, leveraging its unique infant health and sleep data to provide tailored insights for families, enhancing user engagement and creating long-term value.
- Data Privacy Assurance: webAI focuses on private AI systems for sensitive data environments, ensuring that Owlet can adhere to data privacy and compliance requirements as it expands its connected hardware and software, thereby increasing market trust.
- Core Capability Development: Owlet considers AI as a core platform capability, expecting to provide increasingly accurate and personalized insights through training AI on its growing longitudinal data, thus maintaining a competitive advantage in a rapidly evolving market.
- Data-Driven Insights: Owlet's inaugural annual Baby Sleep Report, based on monitoring data from over 1.2 million infants in 2025, analyzes nearly 900 million hours of infant sleep, providing parents with insights into the connection between sleep patterns and overall wellness.
- Health Risk Warning: According to the CDC, approximately 40% of infants aged 4-11 months experience short sleep duration, which is linked to physical and mental health issues; Owlet's report offers practical insights for parents to address these concerns.
- Smart Monitoring Product Advantage: Owlet's Dream Sock® is the only FDA-cleared smart baby wearable monitor on the market, helping families interpret sleep patterns and identify meaningful trends, thereby enhancing parents' confidence in their infants' sleep habits.
- Enhanced User Experience: The Owlet360™ membership service provides deeper trends and analytics, supporting parents in understanding changes in nightly sleep patterns, further solidifying Owlet's leadership in the data-driven infant health sector.
- Price Trend Surge: Owlet, Inc. has seen its stock price increase by 78.4% over the past 12 weeks, reflecting sustained investor confidence in its potential upside, which enhances the company's market appeal.
- Robust Short-Term Performance: The stock's 7.7% price increase over the last four weeks further confirms the continuity of its price trend, bolstering investor confidence in OWLT.
- High Trading Range: Currently trading at 88.7% of its 52-week high-low range, OWLT hints at a potential breakout, attracting increased investor attention.
- Strong Fundamentals: With a Zacks Rank of #1 (Strong Buy), OWLT ranks in the top 5% of over 4,000 stocks, indicating strong fundamentals driven by earnings estimate revisions and EPS surprises, suggesting potential for further price appreciation in the near term.

- Service Innovation: Owlet has launched Owlet360™ in the UK and Ireland, a subscription service designed to provide parents with personalized insights into their baby's sleep and health trends, enhancing their confidence in daily caregiving decisions.
- User Growth: Since its U.S. launch, Owlet360™ has rapidly attracted over 90,000 subscribers, highlighting its relevance in the parenting journey and the resilience of Owlet's recurring revenue model.
- Data-Driven Insights: The service leverages health data from over 2.5 million infants to provide real-time pulse and oxygen monitoring, ensuring parents receive reliable support in everyday decisions, further solidifying Owlet's leadership in infant health monitoring.
- Market Expansion: Owlet360™ is now available to all Owlet Dream App users with a seven-day free trial, with plans for future market expansions, demonstrating the company's strategic focus on global market opportunities.

Small-Cap Stock Performance: Small-cap stocks have seen a rebound in 2024, supported by a low-interest-rate environment, with the Russell 2000 and S&P 600 indices up 13% and 5.3% year-to-date, respectively.
Growth Potential of Small Businesses: Small businesses, reliant on affordable credit, benefit from declining interest rates, which can enhance their profitability and market capitalization, despite being more volatile than larger companies.
Highlighted Small-Cap Stocks: Five small-cap stocks recommended for growth in 2026 include Allot Ltd., Seanergy Maritime Holdings Corp., Isabella Bank Corp., Owlet Inc., and Intellicheck Inc., all holding a Zacks Rank #1 (Strong Buy).
Future Stock Recommendations: Zacks Investment Research plans to release its top 10 stock picks for 2026 on January 5, following a history of significant gains, with the previous top stocks outperforming the S&P 500 substantially.
- International Expansion: Owlet's Dream Sock has received TGA approval in Australia, marking the company's first international expansion into the ANZ market, addressing parents' demand for trusted medical monitoring solutions.
- Product Features: Designed for infants aged 0-18 months, Dream Sock tracks pulse, oxygen levels, and sleep trends in real-time, with the Owlet Dream App providing instant notifications, thereby enhancing parents' ability to make informed care decisions.
- Subscription Service Launch: The introduction of Owlet360 in the ANZ market signifies the international rollout of the company's subscription service, offering personalized guidance and deeper analytics aimed at increasing customer loyalty and recurring high-margin revenue.
- Market Potential: Since 2012, Owlet has assisted over 2.5 million families in monitoring their children's health, and the launch of Dream Sock is expected to further drive the company's market share and brand influence globally.






